Protagenic Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 12 Oct 23 | BuyUS$6,480 | Alexander Arrow | Individual | 8,000 | US$0.81 |
Insider Trading Volume
Compra con información privilegiada: Datos insuficientes para determinar si personas con información privilegiada han comprado más acciones de las que han vendido en los últimos 3 meses.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 9026 | 0,204 % |
| Institutions | 104.153 | 2,35 % |
| Hedge Funds | 240.000 | 5,41 % |
| Individual Insiders | 982.404 | 22,2 % |
| General Public | 3.099.549 | 69,9 % |
Dilución de acciones: Los accionistas se han diluido en el último año, con un crecimiento del total de acciones en circulación de 2.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 743.170 | US$1.2m | 0,63 % | no data | |||
| 240.000 | US$386.4k | 0 % | 0,01 % | |||
| 102.500 | US$165.0k | 0 % | no data | |||
| 61.719 | US$99.4k | 6.170.000 % | no data | |||
| 37.815 | US$60.9k | 0 % | no data | |||
| 37.200 | US$59.9k | 0 % | no data | |||
| 33.166 | US$53.4k | 0,65 % | no data | |||
| 25.199 | US$40.6k | 0 % | no data | |||
| 18.750 | US$30.2k | 0 % | 0,03 % | |||
| 13.812 | US$22.2k | 0 % | no data | |||
| 13.197 | US$21.2k | 0 % | no data | |||
| 9026 | US$14.5k | 59,7 % | no data | |||
| 26 | US$42.1 | 4 % | no data | |||
| 1 | US$1.4 | 0 % | no data | |||
| 1 | US$1.4 | 0 % | no data | |||
| 1 | US$1.4 | 0 % | no data |